Company Filing History:
1 out of 3,540 
1 out of 1,745 
Years Active: 2012
Title: Beatrice Hechler: Innovator in Dendrimer Conjugates
Introduction
Beatrice Hechler is a notable inventor based in Strasbourg, France. She has made significant contributions to the field of pharmacology through her innovative work on dendrimer conjugates. Her research focuses on the development of conjugates that enhance the efficacy of agonists and antagonists of the G-protein coupled receptor (GPCR) superfamily.
Latest Patents
Hechler holds a patent for "Dendrimer conjugates of agonists and antagonists of the GPCR superfamily." This patent discloses conjugates that comprise a dendrimer and a ligand, which is a functionalized congener of an agonist or antagonist of a GPCR. Specifically, the functionalized congener is an adenosine receptor agonist featuring a purine nucleoside moiety and a functional group at the N-position of the purine nucleoside moiety. The functional group has a specific formula that enhances the therapeutic potential of these conjugates. Additionally, the patent includes pharmaceutical compositions, methods for treating various diseases, and a diagnostic method utilizing such conjugates. Hechler has been granted 1 patent for her innovative work.
Career Highlights
Throughout her career, Beatrice Hechler has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the Institut National de la Santé et de la Recherche Médicale. Her work has significantly impacted the field of medical research and drug development.
Collaborations
Hechler has collaborated with esteemed colleagues, including Kenneth Alan Jacobson and Yoonkyung Kim. These collaborations have furthered her research and contributed to advancements in pharmacological applications.
Conclusion
Beatrice Hechler is a pioneering inventor whose work on dendrimer conjugates has the potential to revolutionize treatments for various diseases. Her contributions to the field of pharmacology are noteworthy and continue to inspire future innovations.